Joris Vanderlocht

1.8k total citations
45 papers, 1.2k citations indexed

About

Joris Vanderlocht is a scholar working on Immunology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Joris Vanderlocht has authored 45 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Immunology, 8 papers in Oncology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Joris Vanderlocht's work include Immune Cell Function and Interaction (14 papers), Immunotherapy and Immune Responses (12 papers) and T-cell and B-cell Immunology (11 papers). Joris Vanderlocht is often cited by papers focused on Immune Cell Function and Interaction (14 papers), Immunotherapy and Immune Responses (12 papers) and T-cell and B-cell Immunology (11 papers). Joris Vanderlocht collaborates with scholars based in Netherlands, Belgium and Germany. Joris Vanderlocht's co-authors include Wilfred T.V. Germeraad, Gerard M.J. Bos, Piet Stinissen, Niels Hellings, Catharina Van Elssen, Jerome J. A. Hendriks, Birgit L.M.G. Senden-Gijsbers, Frank Vandenabeele, Tim G. A. M. Wolfs and Mieke Buntinx and has published in prestigious journals such as Blood, PLoS ONE and Cell Metabolism.

In The Last Decade

Joris Vanderlocht

44 papers receiving 1.2k citations

Peers

Joris Vanderlocht
Kai Hübel Germany
Huihui Chen China
Glenn R. Bantug Switzerland
Jens Gerwien Denmark
Simonetta Rizzi Italy
Celine S. Lages United States
Norbert Ahrens Germany
Alvin W. Martin United States
Benedikt Fritzsching Germany
Jussi Niemelä Finland
Kai Hübel Germany
Joris Vanderlocht
Citations per year, relative to Joris Vanderlocht Joris Vanderlocht (= 1×) peers Kai Hübel

Countries citing papers authored by Joris Vanderlocht

Since Specialization
Citations

This map shows the geographic impact of Joris Vanderlocht's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joris Vanderlocht with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joris Vanderlocht more than expected).

Fields of papers citing papers by Joris Vanderlocht

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joris Vanderlocht. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joris Vanderlocht. The network helps show where Joris Vanderlocht may publish in the future.

Co-authorship network of co-authors of Joris Vanderlocht

This figure shows the co-authorship network connecting the top 25 collaborators of Joris Vanderlocht. A scholar is included among the top collaborators of Joris Vanderlocht based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joris Vanderlocht. Joris Vanderlocht is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Libin, Pieter, Lander Willem, Timothy Verstraeten, et al.. (2021). Assessing the feasibility and effectiveness of household-pooled universal testing to control COVID-19 epidemics. PLoS Computational Biology. 17(3). e1008688–e1008688. 23 indexed citations
2.
Torneri, Andrea, Pieter Libin, Joris Vanderlocht, et al.. (2020). A prospect on the use of antiviral drugs to control local outbreaks of COVID-19. BMC Medicine. 18(1). 191–191. 32 indexed citations
3.
Beers, Joyce J. B. C. van, Joris Vanderlocht, Caroline Roozendaal, & Jan Damoiseaux. (2018). Detection of Anti-neutrophil Cytoplasmic Antibodies (ANCA) by Indirect Immunofluorescence. Methods in molecular biology. 1901. 47–62. 8 indexed citations
4.
Elssen, Catharina Van, et al.. (2015). Potency of Both Human Th1 and NK Helper Cell Activation is Determined by IL-12p70-Producing PAMP-Matured DCs. Journal of Interferon & Cytokine Research. 35(9). 748–758. 8 indexed citations
5.
Nikiforou, Maria, Joris Vanderlocht, Claire Chougnet, et al.. (2015). Prophylactic Interleukin-2 Treatment Prevents Fetal Gut Inflammation and Injury in an Ovine Model of Chorioamnionitis. Inflammatory Bowel Diseases. 21(9). 2026–2038. 14 indexed citations
6.
Senden-Gijsbers, Birgit L.M.G., et al.. (2014). Monitoring the Initiation and Kinetics of Human Dendritic Cell-Induced Polarization of Autologous Naive CD4+ T Cells. PLoS ONE. 9(8). e103725–e103725. 7 indexed citations
7.
Jellema, Reint K., Valéria Lima Passos, Daan R. M. G. Ophelders, et al.. (2013). Systemic G-CSF attenuates cerebral inflammation and hypomyelination but does not reduce seizure burden in preterm sheep exposed to global hypoxia–ischemia. Experimental Neurology. 250. 293–303. 25 indexed citations
8.
Jellema, Reint K., Tim G. A. M. Wolfs, Valéria Lima Passos, et al.. (2013). Mesenchymal Stem Cells Induce T-Cell Tolerance and Protect the Preterm Brain after Global Hypoxia-Ischemia. PLoS ONE. 8(8). e73031–e73031. 72 indexed citations
9.
Meek, Bob, Mirelle J.A.J. Huijskens, Joris Vanderlocht, et al.. (2011). T cells fail to develop in the human skin-cell explants system; an inconvenient truth. BMC Immunology. 12(1). 17–17. 12 indexed citations
10.
Goossens, Pieter, Marion J. Gijbels, Alma Zernecke, et al.. (2010). Myeloid Type I Interferon Signaling Promotes Atherosclerosis by Stimulating Macrophage Recruitment to Lesions. Cell Metabolism. 12(2). 142–153. 168 indexed citations
11.
Elssen, Catharina Van, Joris Vanderlocht, Birgit L.M.G. Senden-Gijsbers, et al.. (2010). Klebsiella pneumoniae‐triggered DC recruit human NK cells in a CCR5‐dependent manner leading to increased CCL19‐responsiveness and activation of NK cells. European Journal of Immunology. 40(11). 3138–3149. 32 indexed citations
12.
Elssen, Catharina Van, Henrik Clausen, Wilfred T.V. Germeraad, et al.. (2010). Flow cytometry-based assay to evaluate human serum MUC1-Tn antibodies. Journal of Immunological Methods. 365(1-2). 87–94. 13 indexed citations
13.
Slaets, Helena, Debora Dumont, Joris Vanderlocht, et al.. (2008). Leukemia inhibitory factor induces an antiapoptotic response in oligodendrocytes through Akt‐phosphorylation and up‐regulation of 14‐3‐3. PROTEOMICS. 8(6). 1237–1247. 47 indexed citations
14.
Baeten, Kurt, Jerome J. A. Hendriks, Niels Hellings, et al.. (2008). Visualisation of the kinetics of macrophage infiltration during experimental autoimmune encephalomyelitis by magnetic resonance imaging. Journal of Neuroimmunology. 195(1-2). 1–6. 29 indexed citations
15.
Vanderlocht, Joris, Niels Hellings, Jerome J. A. Hendriks, & Piet Stinissen. (2007). Current trends in multiple sclerosis research: an update on pathogenic concepts. Document Server@UHasselt (UHasselt). 8 indexed citations
16.
Dumont, Debora, Jean‐Paul Noben, Marjan Moreels, et al.. (2007). Characterization of mature rat oligodendrocytes: a proteomic approach. Journal of Neurochemistry. 102(2). 562–576. 18 indexed citations
17.
Vanderlocht, Joris, Niels Hellings, Jerome J. A. Hendriks, & Piet Stinissen. (2007). The Ambivalent Nature of T-Cell Infiltration in the Central Nervous System of Patients with Multiple Sclerosis. Critical Reviews in Immunology. 27(1). 1–14. 7 indexed citations
18.
Vanderlocht, Joris, Niels Hellings, Jerome J. A. Hendriks, et al.. (2006). Leukemia inhibitory factor is produced by myelin‐reactive T cells from multiple sclerosis patients and protects against tumor necrosis factor‐α‐induced oligodendrocyte apoptosis. Journal of Neuroscience Research. 83(5). 763–774. 54 indexed citations
19.
Vanderlocht, Joris, Jerome J. A. Hendriks, Koen Venken, Piet Stinissen, & Niels Hellings. (2006). Effects of IFN-β, leptin and simvastatin on LIF secretion by T lymphocytes of MS patients and healthy controls. Journal of Neuroimmunology. 177(1-2). 189–200. 12 indexed citations
20.
Buntinx, Mieke, Joris Vanderlocht, Niels Hellings, et al.. (2003). Characterization of three human oligodendroglial cell lines as a model to study oligodendrocyte injury: Morphology and oligodendrocyte-specific gene expression. Journal of Neurocytology. 32(1). 25–38. 98 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kai Hübel Breakdown of academic impact, for papers by Huihui Chen Breakdown of academic impact, for papers by Glenn R. Bantug Breakdown of academic impact, for papers by Jens Gerwien Breakdown of academic impact, for papers by Simonetta Rizzi Breakdown of academic impact, for papers by Celine S. Lages Breakdown of academic impact, for papers by Norbert Ahrens Breakdown of academic impact, for papers by Alvin W. Martin Breakdown of academic impact, for papers by Benedikt Fritzsching Breakdown of academic impact, for papers by Jussi Niemelä
Rankless by CCL
2026